282 related articles for article (PubMed ID: 29058119)
1. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours.
Stone TJ; Keeley A; Virasami A; Harkness W; Tisdall M; Izquierdo Delgado E; Gutteridge A; Brooks T; Kristiansen M; Chalker J; Wilkhu L; Mifsud W; Apps J; Thom M; Hubank M; Forshew T; Cross JH; Hargrave D; Ham J; Jacques TS
Acta Neuropathol; 2018 Jan; 135(1):115-129. PubMed ID: 29058119
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
[TBL] [Abstract][Full Text] [Related]
3. Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
Métais A; Appay R; Pagès M; Gallardo C; Silva K; Siegfried A; Perbet R; Maurage CA; Scavarda D; Fina F; Uro-Coste E; Riffaud L; Colin C; Figarella-Branger D;
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12769. PubMed ID: 34551121
[TBL] [Abstract][Full Text] [Related]
4. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
Slegers RJ; Blumcke I
Acta Neuropathol Commun; 2020 Mar; 8(1):27. PubMed ID: 32151273
[TBL] [Abstract][Full Text] [Related]
5. Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma.
Bodi I; Selway R; Bannister P; Doey L; Mullatti N; Elwes R; Honavar M
Neuropathol Appl Neurobiol; 2012 Aug; 38(5):411-25. PubMed ID: 21988102
[TBL] [Abstract][Full Text] [Related]
6. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
7. Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification / characterisation of low grade glioneuronal tumours.
Dyke J; Calapre L; Beasley A; Gray E; Allcock R; Bentel J
Pathol Res Pract; 2022 Jan; 229():153724. PubMed ID: 34942511
[TBL] [Abstract][Full Text] [Related]
8. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
10. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
[TBL] [Abstract][Full Text] [Related]
11. Relationship among clinical, pathological and bio-molecular features in low-grade epilepsy-associated neuroepithelial tumors.
Vornetti G; Marucci G; Zenesini C; de Biase D; Michelucci R; Tinuper P; Tallini G; Giulioni M
J Clin Neurosci; 2017 Oct; 44():158-163. PubMed ID: 28673671
[TBL] [Abstract][Full Text] [Related]
12. Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study.
Fedi M; Anne Mitchell L; Kalnins RM; Gutmann DH; Perry A; Newton M; Brodtmann A; Berkovic SF
J Clin Neurosci; 2004 Sep; 11(7):745-7. PubMed ID: 15337138
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
[TBL] [Abstract][Full Text] [Related]
14. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy.
Aronica E; Yankaya B; Jansen GH; Leenstra S; van Veelen CW; Gorter JA; Troost D
Neuropathol Appl Neurobiol; 2001 Jun; 27(3):223-37. PubMed ID: 11489142
[TBL] [Abstract][Full Text] [Related]
15. The landscape of common genetic drivers and DNA methylation in low-grade (epilepsy-associated) neuroepithelial tumors: A review.
Jesus-Ribeiro J; Rebelo O; Ribeiro IP; Pires LM; Melo JD; Sales F; Santana I; Freire A; Melo JB
Neuropathology; 2022 Dec; 42(6):467-482. PubMed ID: 35844095
[TBL] [Abstract][Full Text] [Related]
16. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
[TBL] [Abstract][Full Text] [Related]
17. The genetic landscape of ganglioglioma.
Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA
Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043
[TBL] [Abstract][Full Text] [Related]
18. [Expression and diagnostic significance of CD34 in brain tumors of patients with refractory epilepsy].
Liu J; Lu DH; Piao YS; Wang W; Chen L; Wei LF; Yang H
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):151-5. PubMed ID: 20450759
[TBL] [Abstract][Full Text] [Related]
19. Seizure outcome of lesionectomy in glioneuronal tumors associated with epilepsy in children.
Giulioni M; Galassi E; Zucchelli M; Volpi L
J Neurosurg; 2005 Apr; 102(3 Suppl):288-93. PubMed ID: 15881752
[TBL] [Abstract][Full Text] [Related]
20. Age at epilepsy onset in patients with focal cortical dysplasias, gangliogliomas and dysembryoplastic neuroepithelial tumours.
Rácz A; Müller AM; Schwerdt J; Becker A; Vatter H; Elger CE
Seizure; 2018 May; 58():82-89. PubMed ID: 29677585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
